Abstract:The study aimed to compare the anti-inflammatory and anti-nociceptive activities of Curcuma wenyujin Y.H. Chen et C. Ling ( Curcuma wenyujin ) and Scutellaria baicalensis Georgi ( Scutellaria baicalensis ). This study used three parts to compare the two herbs. Firstly, animals were randomly divided into a Scutellaria baicalensis group, a Curcuma wenyujin group, an indomethacin group, and a model-control group to perform an ear edema test, a carrageenin-induced paw edema test, a cotton pellet-induced granuloma formation test, and an acetic acid-induced writhing test. Secondly, model rats with pelvic inflammation were established, and the serum levels of TNF-α and IL-6 in each group was detected with the Enzyme-Linked Immunosorbent Assay (ELISA). Thirdly, pharmacokinetics analysis of Scutellaria baicalensis and Curcuma wenyujin was conducted on the model rats. The ear edema test, carrageenin-induced paw edema test, cotton pellet-induced granuloma formation test, and acetic acid-induced writhing test all showed that Curcuma wenyujin had stronger anti-inflammatory and anti-nociceptive effects than Scutellaria baicalensis . There is significant difference between the effects of Curcuma wenyujin and Scutellaria baicalensis on the levels of TNF-α and IL-6 for the model rats. Curcuma wenyujin decreased the levels of TNF-α and IL-6 more than Scutellaria baicalensis . The pharmacokinetics analysis showed that curcumol’s T max , C max , and the area under the curve (AUC) were all higher than baicalin’s. This study indicated that for pelvic inflammation, Curcuma wenyujin had better anti-inflammatory and anti-nociceptive effects than Scutellaria baicalensis . content were taken from the oculi chorioideae vein at 0.083, 0.167, 0.5, 1, 1.5, 2, 3, 4.5, 7, 9, 12 and 24 h following the oral administration. The blood samples for the analysis of baicalin content were taken from the oculi chorioideae vein at 0.25, 0.5, 1, 2, 3, 4, 6, 8, 10, 12 and 24hr following oral administration of the extracts. The blood samples were immediately transferred into heparinized Eppendorf tubes and centrifuged at 3000 rpm for 10 min at 4°C, and then the plasma was obtained. All the plasma samples were stored at −20°C until analysis. The pharmacokinetic parameters, elimination rate constant ( K e), absorption half-life ( T 1/2 α ), and elimination half-life ( T 1/2 β ) were calculated using one or two compartmental methods with 3P87 software (Chinese Society of Mathematical Pharmacology). The area under the curve (AUC) was calculated using the trapezoidal method. The half-life ( T 1/2α and T 1/2β ) values were calculated using the equation: T 1/2 =0.693/ K . The data and the pharmacokinetic parameters were given as mean±SD. actitivies than Scutellaria baicalensis . The results were further confirmed by the experiments conducted on the model rats with pelvic inflammation. The pharmacokinetics analysis conducted on the model rats with pelvic inflammation showed that the AUC of curcumol were higher than those of baicalin, which may be a basis to explain why Curcuma wenyujin led to more satisfactory curative effects than Scutellaria baicalensi when treating pelvic inflammation. Further study with more samples should be conducted on the mechanism and to determine why and how Curcuma wenyujin works to create this stronger effect.

Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats

Comparison of Pharmacokinetics of Baicalein and Baicalin in Rats

Influence of coptis Chinensis on pharmacokinetics of flavonoids after oral administration of radix Scutellariae in rats.

Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract.

Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Radix extract

Absorption and enterohepatic circulation of baicalin in rats

The Effect of Herbal Medicine Baicalin on Pharmacokinetics of Rosuvastatin, Substrate of Organic Anion‐transporting Polypeptide 1B1

Pharmacokinetics and Bioavailability Enhancement of Baicalin: A Review

Population pharmacokinetic analysis of baicalin after oral administration of different Shuang-Huang-Lian formulations to rats

Identification of the Metabolites of Baicalein in Rat Serum

Comparison of anti-inflammatory and anti-nociceptive activities of curcuma

Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases

Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species

The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Pharmacokinetics and Brain Distribution Differences of Baicalin in Rat Underlying the Effect of Panax Notoginsenosides after Intravenous Administration

Identification of the Metabolites of Baicalein in Human Plasma

Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives

Evaluation of Carbonic Anhydrase, Acetylcholinesterase, Butyrylcholinesterase, and α-Glycosidase Inhibition Effects and Antioxidant Activity of Baicalin Hydrate

Effect of Cefradine on Pharmacokinetics of Baicalin in Rats in Vivo